MikeTrendsTrends right now

search

CDK7

Trends

  1. 1

    Researchers report that a drop in certain microRNA levels combined with CDK7 signals may serve as new biomarkers for breast cancer diagnosis. The findings could help detect the disease earlier and improve understanding of tumour biology, though details of the study's methods and scope were not provided.

  2. 2
    Qurient's CDK7 Inhibitor Q901 Shows Synergy with ADCs in Science Advances▼Qurient Announces Publication in Science Advances Demonstrating Synergistic Effect of Selective CDK7 Inhibitor Q901 with TOP1 Inhibitor-Based ADCs✉newsScience4 d ago

    South Korean biotech Qurient announced that its research has been published in Science Advances, showing that its selective CDK7 inhibitor Q901 works synergistically with TOP1 inhibitor-based antibody-drug conjugates. The finding supports combining Q901 with established cancer treatments and may strengthen the company's position in oncology drug development, drawing attention from investors and the biomedical research community.